2022 Conference programme
2022 Conference programme
Look back at the conferences of the 2022 edition:
Steered by a prestigious Committee, the MedFIT conference programme brings together bright minds to discuss the latest trends in MedTech, diagnostic and digital health, to debate on innovation-driven topics, to foster learning and provoke conversations that matter. International experts will address current industry issues related to collaboration, financing, market access and regulation as well as MedTech digitalisation.
-
Plenary Session
-
T.1 - Collaborate to innovate
-
T.2 - Financing innovation
-
T.3 - Innovation to market
-
Project-CEO matchmaking
PLENARY SESSION
DAY ONE - Tuesday, September 20th
Moderated roundtable discussion consisting in an exchange of ideas and perspectives by international experts to delve into the latest challenges of the sector.
- 11:00 AM
- 12:30 PM
Moderator: Thomas Hagemeijer, Healthcare Lead, TLGG Consulting
Building a connected health system and moving towards more preventive medicine requires good use of data. However, the challenges of harnessing the value of health data remain numerous, hindering its use for timely decision making: the volume of data is enormous, as is the speed at which it is generated, and its sources are increasingly varied. Ensuring the veracity of the data and optimising its value is now essential to improve clinical decision-making and fuel tomorrow’s innovation.
This plenary session will explore the business models around health data exploitation and how MedTech innovators can leverage it to differentiate themselves. What are the limitations and constraints that most organisations need to consider when using it? Which legal measures are appropriate to protect critical research data? What are the most pressing barriers to data connectivity? How to strike a balance between unlocking data and securing it, especially for user-generated data? What is to be expected from the newly launched European Health Data Space?
- Baudouin Hue, Partner, Karista
- Vijay Sikka, Chairman & CEO, Sikka Software corporation
- Jennifer Pougnet, Global Data Policy Strategy Leader, Roche
- Jan Beger, Senior Director Digital Ecosystem, GE Healthcare
- Antoine Denis, EMEA Life Sciences Digital Expert, Google Cloud
- Alexandre Moreau-Gaudry, Professor, Université Grenoble Alpes
TRACK 1: COLLABORATE TO INNOVATE
DAY ONE - Tuesday, September 20th
Moderated roundtable discussion consisting in an exchange of ideas and perspectives by international experts to delve into the latest challenges of the sector.
- 3:15 PM
- 4:30 PM
Moderator: Suzanne Elvidge, Freelance writer, Biopharma, Healthcare, Business
Many large medical device companies are now looking externally for new research and development activities by partnering with early stage MedTech companies or Academia. While this may seem riskier, it is now a key way to complement their extensive product portfolio and to meet the growing valuation of potential acquisitions. What are the criteria that drive large MedTech companies to focus either on co-development or licensing? What kind of players are their partner of choice for external innovation? What are the pros and cons of the different approaches? Are there preferred areas (indications, products, families of technology) for these types of collaborations and why?
Introduction: Rogier Receveur, Senior Program Manager Innovation & New Business, EMEA Technology & Innovation, Medtronic Bakken Research Center
“Collaborations between Startup and Big Corporate to boost innovation in MedTech”
Panel discussion:
- Delphine Le Louet, Senior Financial analyst - European Healthcare, Biotech & Medtech, Société Générale
- Ivo Aarninkhof, Managing Director, Holland Innovative
- Antoine Groheux, Innovation Manager, Medtronic
- François Hede, President, Linksium
- Rogier Receveur, Senior Program Manager Innovation & New Business, EMEA Technology & Innovation, Medtronic Bakken Research Center
DAY TWO - Wednesday, September 21st
Moderated roundtable discussion consisting in an exchange of ideas and perspectives by international experts to delve into the latest challenges of the sector.
- 2:00 PM
- 3:30 PM
Moderator: Tobias Silberzahn, Partner, McKinsey & Company and Host, Global Health Tech Network
Over the last two years, hospitals have had to face an unprecedented situation that has profoundly impacted the organisation of care in institutions and the working methods of health professionals. This transformation opens new paths of collaborations to meet the changing challenges of innovation and opportunities for start-ups to develop novel solutions. How are these collaborations built? What are the prospects and concrete examples of accelerated clinical applications? To what extent do these synergies enable the refinement and testing of solutions to best meet the needs and daily practices of healthcare providers?
- Chris Robson, CEO, Living With
- Joop Tanis, Director of MedTech Consulting, Health Tech Enterprise
- Quentin Le Masne, Head of Solution Delivery, Global Digital Health, Merck Group
- Arnaud Attyé, CEO, GeodAlsics
Moderated roundtable discussion consisting in an exchange of ideas and perspectives by international experts to delve into the latest challenges of the sector.
- 10:30 AM
- 11:30 AM
Moderator: Tjasa Zajc, Founder, Host, Faces of digital health
In the age of digital health, strategic collaboration has become more important than ever, but it has also perhaps become more complex as we move from product-based to solution-based innovations. On what basis are start-up/company partnerships built today? What is their geometry and how are they conducted? How can these collaborations be built early to evolve towards other applications and future revenue streams? Who are the new players at the negotiating table? What are the challenges in building these partnerships and how can they be overcome?
- Sheena Pirbhai, Founder & CEO, Stress Point Health
- Jorge Juan Fernández García, Venture Partner, Nina Capital
- Thomas Hummel, Head of Digital Transformation, Fresenius Kabi
- Maxime Cervino, Sales Manager Southern Europe, Chronolife
TRACK 2: FINANCING INNOVATION
DAY ONE - Tuesday, September 20th
Moderated roundtable discussion consisting in an exchange of ideas and perspectives by international experts to delve into the latest challenges of the sector.
- 5:00 PM
- 6:15 PM
Moderator: James Wong, Venture Partner, MedTech SuperConnector
The COVID-19 pandemic has raised awareness of the importance of point-of-care diagnostics and provided an opportunity to rethink and nurture the diagnostic industry. As the pandemic seems to subside, will the interest in IVD diagnostics and more broadly in traditional diagnostic tools persist? More specifically, what types of diagnostics and innovations are attracting early-stage investors today? What are the most pressing unmet needs and what are the major investment trends expected in the coming years for diagnostics? What is the current risk/reward ratio for diagnostic technologies?
- Vincent Poher, Director, Diagnostic Division France, Biosynex
- Cecile Real, CEO, Endodiag
- Antoine Vimont, Head of HealthCare Development, Roche Diagnostics
- Vincent Genet, Vice President Strategy & Business Development – EMEA, Innova Medical Group
Moderated roundtable discussion consisting in an exchange of ideas and perspectives by international experts to delve into the latest challenges of the sector.
- 9:00 AM
- 10:30 AM
Moderator: Jorge Juan Fernández García, Venture Partner, Nina Capital
Your funding strategy goes hand in hand with your business strategy in the early stages of your innovation’s development. It is also crucial to understand how dilution may affect your start-up and to consider alternative financing options. What do you need to consider to find the right balance between dilution and the funds you need to raise? What type of funding and which investors are essential to make it work in the early days? How can your investors also be a resource for your business at the operational level? How can you make the best fundraising decisions to move your business forward and ensure that you have explored all options in a time-sensitive context?
- Judith Zilberstein, CEO, Alon MedTech Ventures
- Neel Patel, Co-Founder & CEO, ZiO Health
- Bruce Lichorowic, President & CEO, Galen Robotics
- Fabian Scheugenpflug, Venture Capital Senior Associate, Plug and Play Tech Center
- Nina Lameule, Investment Manager, NLC - The European Healthtech Venture Builder
DAY TWO - Wednesday, September 21st
Moderated roundtable discussion consisting in an exchange of ideas and perspectives by international experts to delve into the latest challenges of the sector.
- 11:45 AM
- 12:30 PM
Moderator: Arezki Yaiche, Head of Coverage France & Benelux, Mergermarket (ION Group)
MedTech and diagnostic sectors are changing fast with rising digital medical-grade solutions and the expansion of consumer healthcare, creating new sources of innovations and investment opportunities. How is this impacting the landscape for venture capital investment in MedTech in 2022? How are the interest and profile of the early-stage investors evolving through the continuum of MedTech, digital health and consumer healthcare? To what extent does digital health require different approaches and skills? How are investment strategies diversifying with the emergence of new sources of innovations?
- James Wong, Venture Partner, MedTech SuperConnector
- Simon Turner, Partner, Sofinnova Partners
TRACK 3: INNOVATION TO MARKET
DAY ONE - Tuesday, September 20th
Moderated roundtable discussion consisting in an exchange of ideas and perspectives by international experts to delve into the latest challenges of the sector.
- 2:00 PM
- 3:00 PM
Moderator: Przemek Czerklewicz, Principal, Kx Advisors
A go-to-market strategy for MedTech start-up includes a multitude of elements, from regulatory pathway, business and reimbursement models, choice of the first market and commercialisation strategy and much more. As innovators find themselves looking to check all of the boxes on their journey to market, we will ask experienced experienced entrepreneurs and advisors to share their do’s and don’ts for a successful market access strategy.
- Sylvain Poitras, Partner, Appleton Luff
- Esther Rodijk, Project director TTT MedTech, Scout Knowledge Transfer Office, Utwente
- Philippe Cinquin, Professor, Université Grenoble Alpes and Grenoble University Hospital
DAY TWO - Wednesday, September 21st
Moderated roundtable discussion consisting in an exchange of ideas and perspectives by international experts to delve into the latest challenges of the sector.
- 4:00 PM
- 5:00 PM
Moderator: Tobias Silberzahn, Partner, McKinsey & Company and Host, Global Health Tech Network
To what extent is digital health a sector in itself and why? What should be the frame of this sector? How does it relate to, yet differ from, the rest of MedTech and Biotech?
Digital health leaders will share their conception of the sector, how they relate to it, their vision of the challenges and future of digital health.
- Thomas Hummel, Head of Digital Transformation, Fresenius Kabi
- Simon Turner, Partner, Sofinnova Partners
- Géry Pruvost, Strategic Partnership Manager, Lifen
- Etienne Vervaecke, General Manager, Eurasanté
- Anne Mascarelli, Partner & Senior Consultant, Healthcare & Technology International
Moderated roundtable discussion consisting in an exchange of ideas and perspectives by international experts to delve into the latest challenges of the sector.
- 9:00 AM
- 10:00 AM
Moderator: Hugh Harvey, Managing Director, Hardian Health
The years 2021 and 2022 have been intense in terms of regulation for the MedTech sector in Europe, including the implementation of the MDR and IVDR, the advancement of Health Technology Assessment and the proposed EU AI Act. How can MedTech innovators navigate this complex regulatory framework and integrate it in their strategic development? What is the impact on the business model and the cost of the innovation process for small players at early stage? How can regulation be leveraged to be more used as a guide and not only as a constraint?
- Benjamin Faurie, Founder, Electroducer
- Christoph Jo. Müller, Board Co-President, DATEurope
- Kevin van Dooren, Global lead Market Access & Reimbursement – Connected Care, Philips
- David Higgins, Head of Global AI Competence Center, German Entrepreneurship
- Lionel Tussau, Healthcare Market Unit - Global Lead, atrify
PROJECT – CEO MATCHMAKING
DAY ONE - Tuesday, September 20th
Moderated roundtable discussion consisting in an exchange of ideas and perspectives by international experts to delve into the latest challenges of the sector.
- 3:15 PM
- 4:30 PM
Moderator: Eyal Lifschitz, Co-Founder & General Managing Partner, Peregrine Ventures
How to identify and retain talents with the necessary soft skills and technical expertise to drive growth and innovation? How to find the right co-founders? Which networks to activate?
Hear from start-up management savvy experts and receive feedback and best practices.
- Jennifer Goodall, CEO, MindAffect
- Bruce Lichorowic, President & CEO, Galen Robotics
- Marie Laulhé, Innovation and Entrepreneurship Manager, Eurasanté
Continue your tour
Contact
Eline Delcroix
- Conference Programme Manager
- edelcroix@eurasante.com
- +33 (0) 978 315 544